Skip to main content

Main navigation

  • Home
  • Culture
    • Humor
    • Mathematics
    • Random Thoughts
    • Science & Society
    • Sports Science
    • Technology
  • Earth Sciences
    • Atmospheric
    • Energy
    • Environment
    • Geology
    • Oceanography
    • Paleontology
  • Life Sciences
    • Ecology & Zoology
    • Evolution
    • Immunology
    • Microbiology
    • Neuroscience
  • Medicine
    • Aging
    • Cancer Research
    • Clinical Research
    • Pharmacology
    • Public Health
    • Vision
  • Physical Sciences
    • Aerospace
    • Applied Physics
    • Chemistry
    • Optics
    • Physics
    • Space
  • Social Sciences
    • Anthropology
    • Archaeology
    • Philosophy & Ethics
    • Psychology
    • Science History
  • Contributors

User menu

  • Log in
OPERATIC CONCERN

Donate

Please donate so science experts can write for the public.

 

At Science 2.0, scientists are the journalists, with no political bias or editorial control. We can't do it alone so please make a difference.

We are a nonprofit science journalism group operating under Section 501(c)(3) of the Internal Revenue Code that's educated over 300 million people.

You can help with a tax-deductible donation today and 100 percent of your gift will go toward our programs, no salaries or offices.

More reads

Featured Image

Vermont Should Stop Showing Leadership In Overruling Scientists On Farming

Despite Vermont's Agricultural  Innovation Board (AIB), created to inform regulatory recommendations using science, flatly stating there was no basis for a ban on a class of safe pesticides…
Featured Image

Cholestyramine Taken With Daptomycin Prevents Antimicrobial Resistance

Antibiotic resistance is a serious problem. Nature constantly evolves new ways to kill, which means pathogens will develop new methods of resistance to current treatments, but pharmaceutical…
Featured Image

Alzheimer's And Aducanumab: Should Taxpayer Money Be Spent?

In 2019, Biogen announced that it was abandoning its late stage drug for Alzheimer’s, aducanumab but then in 2021 they got FDA approval for it.
Featured Image

GJ 357d, Answer Super Earth or Sub Neptune? Then Report About Life Chances.

At best we can speculate about GJ 357d. The case of GJ 357d we have a scientific paper which is about a planet that is in the habitable zone of its star, is at least six point one times the mass of…

Footer

  • About Us
  • Copyright and Removal
  • Privacy Policy
  • Terms

© 2006-2026 Science 2.0. All rights reserved.